Total Payments
$21,523
2024 Payments
$523.35
Companies
47
Transactions
384
Medicare Patients
795
Medicare Billing
$200,258
Payment Breakdown by Category
Other$13,100 (60.9%)
Food & Beverage$6,792 (31.6%)
Travel$1,496 (7.0%)
Education$135.34 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,100 | 9 | 60.9% |
| Food and Beverage | $6,792 | 364 | 31.6% |
| Travel and Lodging | $1,496 | 7 | 7.0% |
| Education | $135.34 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $11,737 | 74 | $0 (2020) |
| ABBVIE INC. | $2,424 | 46 | $0 (2024) |
| Allergan, Inc. | $2,381 | 16 | $0 (2021) |
| Biogen, Inc. | $662.38 | 31 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $611.09 | 32 | $0 (2024) |
| Daiichi Sankyo Inc. | $604.56 | 34 | $0 (2019) |
| Amgen Inc. | $478.54 | 23 | $0 (2022) |
| Lilly USA, LLC | $428.95 | 22 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $200.00 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $173.29 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.35 | 29 | ABBVIE INC. ($192.45) |
| 2023 | $437.09 | 22 | Lilly USA, LLC ($112.19) |
| 2022 | $723.67 | 36 | Biogen, Inc. ($208.43) |
| 2021 | $3,758 | 74 | AbbVie Inc. ($1,977) |
| 2020 | $2,104 | 37 | Allergan, Inc. ($1,574) |
| 2019 | $639.29 | 25 | Amgen Inc. ($198.67) |
| 2018 | $10,028 | 78 | Supernus Pharmaceuticals, Inc. ($9,348) |
| 2017 | $3,310 | 83 | Supernus Pharmaceuticals, Inc. ($2,343) |
All Payment Transactions
384 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: PAIN | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/30/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Central Nervous System | ||||||
| 08/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Neurology | ||||||
| 08/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Neuroscience | ||||||
| 07/16/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Neurology | ||||||
| 06/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2024 | ABBVIE INC. | BOTOX (Biological), UBRELVY | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/17/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Central Nervous System | ||||||
| 04/01/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Neuroscience | ||||||
| 03/26/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Analgesic | ||||||
| 03/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Neurology | ||||||
| 03/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 162 | 482 | $155,910 | $43,848 |
| 2022 | 4 | 238 | 584 | $192,054 | $55,416 |
| 2021 | 3 | 202 | 563 | $183,668 | $55,387 |
| 2020 | 3 | 193 | 540 | $176,329 | $45,607 |
Total Patients
795
Total Services
2,169
Medicare Billing
$200,258
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 448 | $142,509 | $40,350 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $11,422 | $2,723 | 23.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 11 | 11 | $1,979 | $775.08 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 485 | $154,279 | $44,901 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $28,804 | $7,204 | 25.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 25 | 30 | $5,397 | $2,365 | 43.8% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 11 | 11 | $3,575 | $945.76 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 504 | $160,385 | $48,478 | 30.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $19,865 | $5,304 | 26.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 16 | 19 | $3,418 | $1,605 | 47.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 136 | 479 | $152,370 | $38,980 | 25.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 41 | 41 | $20,361 | $5,025 | 24.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 16 | 20 | $3,598 | $1,602 | 44.5% |
About Dr. Mark Rubino, MD
Dr. Mark Rubino, MD is a Neurology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285605469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Rubino, MD has received a total of $21,523 in payments from pharmaceutical and medical device companies, with $523.35 received in 2024. These payments were reported across 384 transactions from 47 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,100).
As a Medicare-enrolled provider, Rubino has provided services to 795 Medicare beneficiaries, totaling 2,169 services with total Medicare billing of $200,258. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Naples, FL
- Active Since 01/27/2006
- Last Updated 01/02/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285605469
Products in Payments
- TROKENDI XR (Drug) $11,687
- UBRELVY (Drug) $4,415
- Aimovig (Biological) $412.19
- Morphabond ER (Drug) $365.61
- AJOVY (Biological) $306.57
- TYSABRI (Biological) $297.30
- QULIPTA (Drug) $290.30
- Movantik (Drug) $253.98
- EMGALITY (Drug) $248.28
- AMYVID (Drug) $180.67
- Xtampza ER (Drug) $159.04
- Leqembi (Drug) $154.31
- ACTHAR (Biological) $139.80
- AVONEX (Biological) $123.24
- ONZETRA Xsail (Drug) $111.79
- AUBAGIO (Drug) $111.48
- ZEMBRACE SYMTOUCH (Drug) $110.81
- TECFIDERA (Drug) $107.02
- ZOHYDRO ER (Drug) $102.66
- AIMOVIG (Biological) $91.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Naples
Matthew Baker, Md, MD
Neurology — Payments: $1.8M
Neurology $1.8M
William Justiz, Md, MD
Neurology — Payments: $135,961
Neurology $135,961
Dr. Igor Reis, M.d, M.D
Neurology — Payments: $22,365
Neurology $22,365
Ronald Howard, Md, MD
Neurology — Payments: $15,968
Neurology $15,968
Dr. Michael Novak, Md, MD
Neurology — Payments: $14,679
Neurology $14,679
Pedro Garciarena, M.d, M.D
Neurology — Payments: $14,132
Neurology $14,132